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The bacterial cbb3 cytochrome oxidase is a member of the heme-
copper oxidase (HCO) superfamily, which couples the reduction of
molecular oxygen to transmembrane proton pumping. The cbb3
oxidases are characterized by a higher catalytic activity at low oxygen
concentrations [1]. The presence of the cbb3 cytochrome oxidase is
considered to be essential for the pathogenicity of many bacterial
species.
Pseudomonas stutzeri ZoBell contains two independent operons
encoding cbb3-isoforms, Cbb3-1 and Cbb3-2, respectively [2]. The X-
ray structure of Cbb3-1 at 3.2 Å resolution showed an electron
transfer pathway that differs from the mitochondria-like oxidases
(family A) and the Thermus thermophilus ba3-like oxidase (family B).
Moreover, structural differences around heme b and heme b3-CuB
binuclear center and the existence of one proton pathway possibly
indicate a different redox-driven proton pumping mechanism.
To investigate structural and functional details of both isoforms, each
of the two operons has been deleted by homologous recombination.
These deletion strains are used for the expression of recombinant tagged
cbb3-isoforms. Both homologously produced isoforms were isolated
and identiﬁed by in-gel detection using TMBZ/H2O2 assay and
electrospray ionization mass spectrometry (ESI-MS). Compared with
Cbb3-1, Cbb3-2 showed a low level of expression under both aerobic
and micro-aerobic growth conditions. Promoter exchange has been used
to increase the yield of Cbb3-2. Both puriﬁed isoforms showed similar
oxygen reduction activities. No signiﬁcant difference was found
between the wild-type cbb3 oxidase and both recombinant isoforms.
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Reperfusion injury plays a major role in tissue damage in many
diseases including stroke and myocardial infarction, when oxygen is
let back into the ischemic tissue. The pathologic effect of reperfusion
has largely been attributed to the production of reactive oxygen
species (ROS) by mitochondria, which are generated at high
mitochondrial membrane potentials (ΔΨm). Traditional pharmaco-
logic therapies attempting to scavenge ROS have failed, possibly due
to inherent difﬁculties in delivery of drugs to sub-cellular targets
during the crucial early reperfusion phase. Here, we applied a non-
pharmacologic strategy, that targets cytochrome c oxidase (COX),
which acts as a photo-acceptor for infrared light (IRL). We discovered
4 speciﬁc IRL wavelengths that reduce the activity of COX. Our model
proposes that such IRL should normalize ΔΨm through inhibition of
COX, which contributes to the generation of ΔΨm. We tested this
hypothesis in an adult rat model of global brain ischemia/reperfusion
injury. All single, double, triple, and quadruple wavelength combina-
tions that reduce COX activity were evaluated for neuroprotection
using a randomized and blinded study design (15 treatment groups).
IRL was applied at the onset of reperfusion and maintained for 2 h.
After 14 days, brains were analyzed via counting of CA1 hippocampal
neurons. In untreated animals subjected to global brain ischemia 88%
of neurons were lost. Strikingly, for the 15 IRL combination groups,
loss of neurons ranged from only 11% for the best treatment regimen
to 42%. The signiﬁcant neurologic protection observed in IRL treated
rats also coincided with preservation of neurologic function. To gain
further insight into the mechanism of neuroprotection conferred by
IRL we utilized in situ detection of mitochondrial superoxide
generation. In untreated animals ischemia/reperfusion induced a 7-
fold increase in MitoSOX ﬂuorescence, indicative of mitochondrial
ROS production, whereas animals treated with IRL showed ﬂuores-
cent signals similar to controls. These data demonstrate the potential
neuroprotective effect of non-invasive modulation of mitochondrial
function with speciﬁc IRL.
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